Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: Solid Biosciences Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Solid Biosciences Inc. June 6, 202399.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 20, 2026 | Kailera Therapeutics Inc. | Derivative conversion | +16,875,000 | — | — |
| Apr 20, 2026 | Kailera Therapeutics Inc. | Derivative conversion | +4,145,768 | — | — |
| Apr 20, 2026 | Kailera Therapeutics Inc. | Open-market purchase | +1,562,500 | $16.00 | $25,000,000 |
| Jan 11, 2024 | Solid Biosciences Inc. | Grant or award | +904,160 | $5.53 | $5,000,005 |
Questions about Adam Koppel
What boards is Adam Koppel on?
Adam Koppel sits on the boards of Foghorn Therapeutics Inc., Kailera Therapeutics Inc. and Solid Biosciences Inc.
How long has Adam Koppel served on boards?
Our records show at least 7 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.